Blood‐based detection of <i><scp>RAS</scp></i> mutations to guide anti‐<scp>EGFR</scp> therapy in colorectal cancer patients: concordance of results from circulating tumor <scp>DNA</scp> and tissue‐based <i><scp>RAS</scp></i> testingWolff Schmiegel, Stephen B. Fox, Cliff Meldrum et al.|Molecular Oncology|2017Cited by 161
P-273 Concordance of RAS mutation status in CRC patients by comparison of results from circulating tumour DNA and tissue-based testingRodney J. Scott, Stephen B. Fox, S Dooley et al.|Annals of Oncology|2015Cited by 1